Skip to content
Biodatica
Start free

Investigator

Milton L Greenberg

VIVREON BIOSCIENCES, LLC · funded by NIA, NIDA, NIAID

Companies
3

Resolved onto their grants.

Grants
4

Federal awards on file.

Non-dilutive funding
$6.0M

Summed across those awards.

First award
May 1, 2022

Latest Jul 1, 2025.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. SB1

    Preclinical Characterization of CRAC Channel Inhibitors for the Treatment of Alzheimer's Disease

    $2.0M

    Jul 1, 2025NIAVIVREON BIOSCIENCES, LLCNIH RePORTER · 11068859 (opens the source filing in a new tab)

  2. SB1

    Preclinical Characterization of CRAC Channel Inhibitors for the Treatment of Alzheimer's Disease

    $1.9M

    Jul 1, 2025NIAVIVREON BIOSCIENCES, LLCNIH RePORTER · 11370083 (opens the source filing in a new tab)

  3. R44

    Development of a Novel Calcium Channel Therapeutic for Opioid Use Disorder

    $1.1M

    Jul 15, 2023NIDAVIVREON BIOSCIENCES, LLCNIH RePORTER · 11135560 (opens the source filing in a new tab)

  4. R44

    Predevelopment of VV8220, a Gut-selective CRAC Channel Therapeutic for Ulcerative Colitis

    $1000k

    May 1, 2022NIAIDVIVREON BIOSCIENCES, LLCNIH RePORTER · 11159849 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources